AGITG Trial News

The AGITG currently has eight  studies open to recruitment and ten  studies in follow up.

The  table below details  the trials that  are currently  accruing patients.

Recruited

Target

ACTICCA-1- Gallbladder carcinoma 2 50
ALT-GIST- GI Stromal Tumour 44 60
ASCOLT — Colorectal cancer 197 300
CONTROL NETs — NeuroEndocrine Tumour 46 73
INTERAACT — Anal cancer 1 20
INTEGRATE II –  Gastro-Oesophageal 6 350
NABNEC  — NeuroEndocrine Tumour 1 70
TOP GEAR — Stomach cancer 337 752

Recruitment figures to end  February 2017.

 

Trial Results Lay Summaries (click on the links below):

ALaCaRT

ATTACHE

ATTAX-3

GAP

ICECREAM

INTEGRATE

TACTIC

TOP GEAR

CO.17